Breast cancer: The Lancet Oncology: Aug 6, 2015

The Lancet Oncology in conversation with - A podcast by The Lancet Group

Categories:

Education

Harry Bear discusses the use of adjuvant and neoadjuvant bevacizumab in the treatment of early breast cancer. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv